French group Eurofins launches new, lower-cost COVID-19 test

French diagnostics company Eurofins is launching a new, lower-cost product to detect the presence of SARS-CoV-2 virus responsible for the COVID-19 disease, the company said on Thursday.

PARIS, Aug 5 (Reuters) - French diagnostics company Eurofins EUFI.PA is launching a new, lower-cost product to detect the presence of SARS-CoV-2 virus responsible for the COVID-19 disease, the company said on Thursday.

For the testing, Eurofins will pool five specimens and then undertake a single Polymerase Chain Reaction (PCR) test while retaining the original, individual samples, with results typically provided within 24-48 hours, said Eurofins.

If SARS-CoV-2 is detected in the pool, individual PCR tests will be performed to definitively identify the individual sample(s) that were positive. If there is no virus detected in the pool, no further testing is required, the company said.

(Reporting by Sudip Kar-Gupta Editing by Shri Navaratnam)

((sudip.kargupta@thomsonreuters.com; +33 1 49 49 53 84;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More